| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.32 | 0.03 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.03 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.04 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.095 | 0.06 |